Aaron Paul Kithcart: When Clinical Research Comes Together at ISTH 2026
Aaron Paul Kithcart, Senior Medical Director in Translational and Clinical Sciences of Hematology at Regeneron, shared a post on LinkedIn:
“Just returned from Paris for ISTH, and the only thing hotter than the conference was the temperature. Seriously!
We shared new data from our FXI and FXII programs, which is always a great opportunity to learn from global leaders in thrombosis. The whole team learned a lot from our interactions, proving once again the value of in person meetings.
We also sat down with investigators for our ongoing and future studies. Nothing replaces a real conversation, clinical research really is a partnership, and I appreciate those who set aside time to talk to us.
And honestly, half the value of ISTH is catching up with colleagues I only see once a year. See you again in Vancouver in 2027!”
Stay updated with Hemostasis Today.
-
Aug 14, 2026, 15:53Peter Jaworski: Plasma Donation Myths and Why Plasma Matters
-
Aug 14, 2026, 15:50John Strouse: Why Older Adults with Sickle Cell Disease Should Be Included in Clinical Trials
-
Aug 14, 2026, 15:44Scott Cameron: Understanding Sex Differences in Platelet Biology
-
Aug 14, 2026, 15:35Daniel Witt: Why Patient Education Matters in Anticoagulation Care
-
Aug 14, 2026, 15:29William Wallace: ApoB May Reveal the Risk Hidden Behind Normal LDL
-
Aug 14, 2026, 15:14Alejandro González Veliz: Could a Simple Flu Shot Save Lives After a Heart Attack?
-
Aug 14, 2026, 14:44Building Community and Hope for a Cure with the Glanzmann’s Research Foundation
-
Aug 14, 2026, 14:36Salih Ehsan: Global Bosses of Hemoglobinopathy Traits
-
Aug 14, 2026, 14:33Wolfgang Miesbach: Modern Hemophilia Therapies and the Challenges of Laboratory Monitoring